Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Karex BhdXKLS:5247 39 Debt-to-EBITDA is -11.46 as of Mar. 2026. GuruFocus rates XKLS:5247 with a GF Score™ of 39/100 and a GF Value™ of RM0.77 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,552 Consumer Packaged Goods companies, Karex Bhd ranks worse than 64432.93% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Karex Bhd's Debt-to-EBITDA or its related term are showing as below:
XKLS:5247'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -19.14 Med: 1.99 Max: 5.92
Current: -19.14
During the past 13 years, the highest Debt-to-EBITDA Ratio of Karex Bhd was 5.92. The lowest was -19.14. And the median was 1.99.
XKLS:5247's Debt-to-EBITDA is ranked worse than 100% of 1552
companies
in the Consumer Packaged Goods industry
Industry Median: 2.065
vs XKLS:5247: -19.14
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Karex Bhd Debt-to-EBITDA Related Terms
Karex Bhd Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Karex Bhd's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:5247 vs PG, CL, KVUE: Debt-to-EBITDA Comparison
For the Household & Personal Products subindustry, Karex Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Karex Bhd Debt-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Karex Bhd's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Karex Bhd's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Karex Bhd (XKLS:5247) has a Debt-to-EBITDA of -11.46 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Karex Bhd. According to the industry distribution chart, Karex Bhd ranks #999999 out of 1552 companies in the Consumer Packaged Goods industry.
Is Karex Bhd's Debt-to-EBITDA too high?
Karex Bhd's current Debt-to-EBITDA is -11.46. Based on the distribution chart, Karex Bhd ranks #999999 out of 1552 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Karex Bhd has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Karex Bhd's Debt-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Karex Bhd ranks #999999 out of 1552 companies for Debt-to-EBITDA. This places Karex Bhd in the lower half of its industry. The industry median Debt-to-EBITDA is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Consumer Packaged Goods company?
The median Debt-to-EBITDA among Consumer Packaged Goods companies is 2.07, based on 1,552 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Karex Bhd. For the Consumer Packaged Goods industry, the median Debt-to-EBITDA is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Karex Bhd's current Debt-to-EBITDA is -11.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Karex Bhd stock overvalued right now?
Based on GuruFocus' analysis, Karex Bhd (XKLS:5247) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.77, compared to a current price of RM0.49 — trading 36.4% below its estimated fair value. The current Debt-to-EBITDA is -11.46. Karex Bhd's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Karex Bhd (XKLS:5247), the current Debt-to-EBITDA is -11.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Karex Bhd (XKLS:5247) Overvalued in 2026?
Based on GuruFocus' analysis, Karex Bhd stock appears to be undervalued.
The current stock price of RM0.49 is trading 36.4% below its estimated GF Value™ of RM0.77.
GuruFocus considers Karex Bhd to be Possible Value Trap.
Key valuation signals for XKLS:5247:
Debt-to-EBITDA: -11.46
GF Value™: RM0.77 vs. price of RM0.49 (36.4% below fair value)
No single metric tells the full story. See the XKLS:5247 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Karex Bhd is a Malaysian investment holding company. Along with its subsidiaries, its main business activities comprise investment holding, manufacture, and sale of sexual wellness, medical, and other health-related products. These activities are located in Malaysia, Thailand, the United States of America, and the United Kingdom. It is principally engaged in manufacturing and selling condoms, personal lubricants, latex probe covers, oral dams, and others. The operating segments of the company are Sexual wellness, which generates maximum profits, Medical, and Others. Geographically, it derives key revenue from the Americas and the rest from Asia, Europe, and Africa.
39GF Score
Get the complete analysis for XKLS:5247
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5247 has been successfully added to your 
